Quick Answer
Anixa Biosciences Inc reported Cash And Cash Equivalents At Carrying Value of $1.24 million for the year ending 2025.
- Anixa Biosciences Inc showed a decrease of -2.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Anixa Biosciences Inc's Cash And Cash Equivalents At Carrying Value has declined by 14.3%.
- Historical annual values: Fiscal year 2025: $1.24 million | Fiscal year 2024: $1.27 million | Fiscal year 2023: $915.0 thousand | Fiscal year 2022: $12.36 million | Fiscal year 2021: $29.13 million | Fiscal year 2020: $6.42 million | Fiscal year 2019: $3.49 million | Fiscal year 2018: $3.06 million | Fiscal year 2017: $3.34 million | Fiscal year 2016: $2.49 million | Fiscal year 2015: $4.37 million | Fiscal year 2014: $3.36 million | Fiscal year 2013: $898.2 thousand | Fiscal year 2012: $339.7 thousand | Fiscal year 2011: $774.0 thousand | Fiscal year 2010: $1.09 million | Fiscal year 2009: $1.45 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: